Skip to content

Overview
Stock
News & Events
Governance
Financials
- SEC Filings
- Quarterly Results
Resources

Event Details

Biodesix Q4 2024 Earnings Conference Call

March 3, 2025 4:30 PM EST

Click here for webcast

The tests on this website have been developed and validated by Biodesix, Inc. and their performance characteristics have been reviewed and approved by the New York State Clinical Evaluation Program (NYS CLEP). They have not yet been cleared nor approved by the US Food and Drug Administration.

TESTS

Tests Overview
Nodify Lung^® Nodule Risk Assessment
IQLung™ Cancer Treatment Guidance

SERVICES

Services Overview
Biopharma Services
Life Sciences Services

RESOURCES

Physician Portal
Nodule Risk Calculator
Publications
Reimbursement
Labs Certifications

ABOUT

Company
Careers
Newsroom
Investors

Contact Us

Privacy Policy & HIPAA
Terms & Conditions
GDPR Notice
No Surprises Act

©2025 Biodesix. All Rights Reserved